Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N0PU
|
||||
Former ID |
DCL000155
|
||||
Drug Name |
LTB 019
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Discontinued in Phase 2 | [547374] | ||
Company |
Novartis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H35N3O4
|
||||
Canonical SMILES |
CC(C)N(C(C)C)C(=O)C1=CC(=C(C=C1)OCCCCCOC2=CC=C(C=C2)C(=<br />N)N)O
|
||||
InChI |
1S/C25H35N3O4/c1-17(2)28(18(3)4)25(30)20-10-13-23(22(29)16-20)32-15-7-5-6-14-31-21-11-8-19(9-12-21)24(26)27/h8-13,16-18,29H,5-7,14-15H2,1-4H3,(H3,26,27)
|
||||
InChIKey |
LBVCAMSVLTWBRT-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Leukotriene B4 receptor 1 | Target Info | Antagonist | [536562] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL4 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.